Patient Guide: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 358 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05803421
Status: ACTIVE_NOT_RECRUITING
Condition: Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease
Phase: PHASE3

Find a Study Location Near You

This study is available at 358 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Daphne, Alabama
  • Mobile, Alabama
  • Pelham, Alabama
  • • And 355 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily